FIELD: medicine. SUBSTANCE: invention proposes the application of lithium ascorbate known early as an anti-viral agent as an agent for the enhancement of activity of neutrophiles. EFFECT: expanded assortment of agents of claimed designation. 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| IMMUNOSTIMULATING AND ANTIOXIDANT COMPOSITION | 2008 |
|
RU2372081C1 |
| IMMUNOSTIMULATING DRUG | 2012 |
|
RU2480223C1 |
| IMMUNOMODULATORY AGENT | 2024 |
|
RU2833174C1 |
| IMMUNOMODULATORY AND ANTI-INFECTIOUS COMPOSITION | 2011 |
|
RU2448691C1 |
| AGENT INDUCING PRODUCTION OF INTERLEUKIN-8 | 2019 |
|
RU2712785C1 |
| MEDIATION, POSSESSING HAEMATOPROTACTING EFFECT | 2006 |
|
RU2351326C2 |
| METHOD OF IMPROVING AND STABILISING ANTIOXIDANT PROPERTIES OF ALCOHOLIC BEVERAGES | 2016 |
|
RU2609642C1 |
| METHOD FOR OBTAINING A HERBAL FORMULATION TO INCREASE IMMUNITY IN BACTERIAL INFECTIONS OF CATTLE | 2021 |
|
RU2776238C1 |
| CYTOSTATIC AND ANTIVIRAL COMPOSITION | 1995 |
|
RU2094048C1 |
| COMPOSITION WITH IMMUNOPOTENTIATING PROPERTIES | 2006 |
|
RU2348416C2 |
Authors
Dates
2004-04-10—Published
2002-05-28—Filed